Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP).
VIP receptors are frequently overexpressed by various endocrine tumors. In this study the expression of VIP receptors in the human adrenocortical carcinoma cell line NCI-H295 and their involvement in the regulation of steroidogenesis was investigated. NCI-H295 cells express VIP1 and VIP2 receptors as demonstrated by RT-PCR, whereas they do not express VIP itself. The receptors are functionally coupled to steroidogenesis since VIP (10(-9) M to 10(-6) M) exerted a dose-dependent stimulatory effect on the release of aldosterone, cortisol, and DHEA. VIP increased ACTH-stimulated releases of aldosterone and cortisol. The proliferation rate of NCI-H295 cells was not affected by VIP. These data show that NCI-H295 cells express both forms of the VIP receptor and that VIP is involved in an ACTH-independent regulation of steroidogenesis in the adrenal tumor cells.
Haidan
A
A
Department of Internal Medicine III, University of Leipzig, Germany.
Hilbers
U
U
Bornstein
S R
SR
Ehrhart-Bornstein
M
M
D000302:Adrenal Cortex / Q000187:drug effects*; D000305:Adrenal Cortex Hormones / Q000096:biosynthesis*; D000306:Adrenal Cortex Neoplasms / Q000378:metabolism; D000450:Aldosterone / Q000096:biosynthesis; D003687:Dehydroepiandrosterone / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006854:Hydrocortisone / Q000096:biosynthesis; D018005:Receptors, Vasoactive Intestinal Peptide / Q000378:metabolism*; D014407:Tumor Cells, Cultured / Q000187:drug effects* / Q000473:pathology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
D000305:Adrenal Cortex Hormones; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide; D003687:Dehydroepiandrosterone; D000450:Aldosterone; D006854:Hydrocortisone